Lipid Composition for FADG-201Amount (µmol/vial)Amount (mg/vial)Molar Ratio Percentage
Total µmol/vial mg/vial100
1,2-dioleoyl-3-trimethylammonium-propane (chloride salt)65
Cholesterol29
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)- 2000] (ammonium salt)5
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (ammonium salt) (NBD PE)1
Lipid Composition for FADG-202Amount (µmol/vial)Amount (mg/vial)Molar Ratio Percentage
Total µmol/vialmg/vial100
1,2-dioleoyl-3-trimethylammonium-propane (chloride salt)60
1,2-dioleoyl-sn-glycero-3-phosphocholine5
Cholesterol29
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)- 2000] (ammonium salt)5
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (ammonium salt) (NBD PE)1
Lipid Composition for FADG-203Amount (µmol/vial)Amount (mg/vial)Molar Ratio Percentage
Total µmol/vial mg/vial100
1,2-dioleoyl-3-trimethylammonium-propane (chloride salt)50
1,2-dioleoyl-sn-glycero-3-phosphocholine15
Cholesterol29
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)- 2000] (ammonium salt)5
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (ammonium salt) (NBD PE)1
Lipid Composition for FADG-204Amount (µmol/vial)Amount (mg/vial)Molar Ratio Percentage
Total µmol/vialmg/vial100
1,2-dioleoyl-3-trimethylammonium-propane (chloride salt)40
1,2-dioleoyl-sn-glycero-3-phosphocholine25
Cholesterol29
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)- 2000] (ammonium salt)5
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (ammonium salt) (NBD PE)1
Lipid Composition for FADG-205Amount (µmol/vial)Amount (mg/vial)Molar Ratio Percentage
Total µmol/vial mg/vial100
1,2-dioleoyl-3-trimethylammonium-propane (chloride salt)30
1,2-dioleoyl-sn-glycero-3-phosphocholine35
Cholesterol29
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)- 2000] (ammonium salt)5
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (ammonium salt) (NBD PE)1
Lipid Composition for FADG-206Amount (µmol/vial)Amount (mg/vial)Molar Ratio Percentage
Total µmol/vial mg/vial100
1,2-dioleoyl-3-trimethylammonium-propane (chloride salt)20
1,2-dioleoyl-sn-glycero-3-phosphocholine45
Cholesterol29
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)- 2000] (ammonium salt)5
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (ammonium salt) (NBD PE)1
Lipid Composition for FADG-207Amount (µmol/vial)Amount (mg/vial)Molar Ratio Percentage
Total µmol/vialmg/vial100
1,2-dioleoyl-3-trimethylammonium-propane (chloride salt)10
1,2-dioleoyl-sn-glycero-3-phosphocholine55
Cholesterol29
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)- 2000] (ammonium salt)5
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (ammonium salt) (NBD PE)1
Lipid Composition for FADG-208Amount (µmol/vial)Amount (mg/vial)Molar Ratio Percentage
Total µmol/vialmg/vial100
1,2-dioleoyl-3-trimethylammonium-propane (chloride salt)5
1,2-dioleoyl-sn-glycero-3-phosphocholine60
Cholesterol29
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)- 2000] (ammonium salt)5
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (ammonium salt) (NBD PE)1
Lipid Composition for FADG-209Amount (µmol/vial)Amount (mg/vial)Molar Ratio Percentage
Total µmol/vial mg/vial100
1,2-dioleoyl-3-trimethylammonium-propane (chloride salt)2.5
1,2-dioleoyl-sn-glycero-3-phosphocholine62.5
Cholesterol29
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)- 2000] (ammonium salt)5
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (ammonium salt) (NBD PE)1
Lipid Composition for FADG-210Amount (µmol/vial)Amount (mg/vial)Molar Ratio Percentage
Total µmol/vial mg/vial100
1,2-dioleoyl-3-trimethylammonium-propane (chloride salt)1
1,2-dioleoyl-sn-glycero-3-phosphocholine64
Cholesterol29
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)- 2000] (ammonium salt)5
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (ammonium salt) (NBD PE)1
Lipid Composition for FADG-211Amount (µmol/vial)Amount (mg/vial)Molar Ratio Percentage
Total µmol/vial mg/vial100
1,2-dioleoyl-3-trimethylammonium-propane (chloride salt)65
Cholesterol29
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)- 2000] (ammonium salt)5
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (ammonium salt) (Rhod PE)1
Lipid Composition for FADG-212Amount (µmol/vial)Amount (mg/vial)Molar Ratio Percentage
Total µmol/vial mg/vial100
1,2-dioleoyl-3-trimethylammonium-propane (chloride salt)60
1,2-dioleoyl-sn-glycero-3-phosphocholine5
Cholesterol29
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)- 2000] (ammonium salt)5
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (ammonium salt) (Rhod PE)1
Lipid Composition for FADG-213Amount (µmol/vial)Amount (mg/vial)Molar Ratio Percentage
Total µmol/vial mg/vial100
1,2-dioleoyl-3-trimethylammonium-propane (chloride salt)50
1,2-dioleoyl-sn-glycero-3-phosphocholine15
Cholesterol29
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)- 2000] (ammonium salt)5
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (ammonium salt) (Rhod PE)1
Lipid Composition for FADG-214Amount (µmol/vial)Amount (mg/vial)Molar Ratio Percentage
Total µmol/vial mg/vial100
1,2-dioleoyl-3-trimethylammonium-propane (chloride salt)40
1,2-dioleoyl-sn-glycero-3-phosphocholine25
Cholesterol29
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)- 2000] (ammonium salt)5
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (ammonium salt) (Rhod PE)1
Lipid Composition for FADG-215Amount (µmol/vial)Amount (mg/vial)Molar Ratio Percentage
Total µmol/vial mg/vial100
1,2-dioleoyl-3-trimethylammonium-propane (chloride salt)30
1,2-dioleoyl-sn-glycero-3-phosphocholine35
Cholesterol29
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)- 2000] (ammonium salt)5
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (ammonium salt) (Rhod PE)1
Lipid Composition for FADG-216Amount (µmol/vial)Amount (mg/vial)Molar Ratio Percentage
Total µmol/vial mg/vial100
1,2-dioleoyl-3-trimethylammonium-propane (chloride salt)20
1,2-dioleoyl-sn-glycero-3-phosphocholine45
Cholesterol29
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)- 2000] (ammonium salt)5
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (ammonium salt) (Rhod PE)1
Lipid Composition for FADG-217Amount (µmol/vial)Amount (mg/vial)Molar Ratio Percentage
Total µmol/vial mg/vial100
1,2-dioleoyl-3-trimethylammonium-propane (chloride salt)10
1,2-dioleoyl-sn-glycero-3-phosphocholine55
Cholesterol29
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)- 2000] (ammonium salt)5
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (ammonium salt) (Rhod PE)1
Lipid Composition for FADG-218Amount (µmol/vial)Amount (mg/vial)Molar Ratio Percentage
Total µmol/vial mg/vial100
1,2-dioleoyl-3-trimethylammonium-propane (chloride salt)5
1,2-dioleoyl-sn-glycero-3-phosphocholine60
Cholesterol29
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)- 2000] (ammonium salt)5
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (ammonium salt) (Rhod PE)1
Lipid Composition for FADG-219Amount (µmol/vial)Amount (mg/vial)Molar Ratio Percentage
Total µmol/vial mg/vial100
1,2-dioleoyl-3-trimethylammonium-propane (chloride salt)2.5
1,2-dioleoyl-sn-glycero-3-phosphocholine62.5
Cholesterol29
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)- 2000] (ammonium salt)5
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (ammonium salt) (Rhod PE)1
Lipid Composition for FADG-220Amount (µmol/vial)Amount (mg/vial)Molar Ratio Percentage
Total µmol/vial mg/vial100
1,2-dioleoyl-3-trimethylammonium-propane (chloride salt)1
1,2-dioleoyl-sn-glycero-3-phosphocholine64
Cholesterol29
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)- 2000] (ammonium salt)5
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (ammonium salt) (Rhod PE)1
Recent Clients